Publications — Neisseria meningitidis
Return to Publications Menu
2006 to present:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2006 -- Provisional. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening06.pdf
Borrow R, Carlone GM, Rosenstein N, Blake M, Feavers I, Martin D, Zollinger W, Stephens DS, and The Meningococcal Working Group. Neisseria meningitidis group B correlates of protection and assay standardization - International Meeting Report, Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine 2006;24:5093-107.
Harrison LH, Jolley KA, Shutt KA, Marsh JW, O'Leary M, Thomson Sanza L, Maiden MCJ. Antigenic shift and the incidence of meningococcal infection. J Infect Dis In press.
Harrison LH, Maiden MC. Reply to Tsang et al. J Infect Dis 2006;194:1792-3.
Back to Top
2000-2005:
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2005. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening05.pdf
Centers for Disease Control and Prevention. Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005; 54(RR-7):1-21.
Dull P, Abdelwahab J, Sacchi C, Becker M, Noble C, Kaiser R, Mayer L, Whitney A, Schmink S, Dolan-Livengood J, Stephens DS, Ajello G, Creton M, Popovic T, Rosenstein N. Serogroup W-135 Neisseria meningitidis carriage among U.S. travelers to the 2001 Hajj. J Infect Dis 2005;191:33-9.
Sejvar JJ, Johnson D, Popovic T, Miller JM, Downes F, Somsel P, Weyant R, Stephens DS, Perkins B, Rosenstein NA. Assessing the risk of laboratory-acquired meningococcal disease in the United States, 1996-2000. J Clin Microbiol 2005;24:4811-4.
Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States. Pediatrics 2005;115(5):1220-32.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2004. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening04.pdf
McEllistrem MC, Kolano JA, Pass MA, Caugant DA, Mendelsohn A, Pacheco AGF, Shutt KA, Razeq J, Harrison LH. Epidemiologic trends and genotypes causing meningococcal disease, Maryland. Emerg Infect Dis 2004;10:451-456.
Mothershed EA, Sacchi CT, Whitney AM, Barnett GA, Ajello GW, Schmink S, Mayer LW, Phelan M, Taylor TH, Bernhardt SA, Rosenstein NE, Popovic T. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 2004; 42:320-328.
Raghunathan PL, Bernhardt SA, Rosenstein NE. Opportunities for control of meningococcal disease in the United States. Ann Rev Med 2004;55:333-353.
Zimmer S, Stephens DS. Meningococcal conjugate vaccine. Expert Opin Pharmacother 2004;4:855-63.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2003. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening03.pdf
Dolan-Livengood JM, Miller YK, Kahler CM, Reeves M, Ajello G, Stephens DS. Genetic basis for nongroublable Neisseria meningitidis . J Jnfect Dis 2003;187:1616-28.
Shepard CW, Rosenstein NE, Fischer M, and the Active Bacterial Core Surveillance Team. Neonatal meningococcal disease in the United States, 1990-1999. Pediatr Infect Dis J, 2003 ;22:418-422.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2002. Available via the internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening02.pdf
Kellerman S, McCombs K, Ray M, Farley MM, Rosenstein N, Popovic T, Blake P, Stephens DS, and the Georgia Emerging Infections Program. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease. J Infect Dis 2002;186:40-48.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2001. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening01.pdf
Finn R, Groves C, Coe M, Pass M, Harrison LH. A cluster of serogroup C meningococcal disease associated with attendance at a party. South Med J 2001;94(12):1192-1194.
Harrison LH, Pass MA, Mendelsohn AB, Egri M, Pass M, Rosenstein NE, Razeq J, Roche JC. Invasive meningococcal disease in adolescents and young adults. JAMA 2001;286:694-699.
Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA and the Active Bacterial Core Surveillance (ABCs) Team. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States. Vaccine 2001;19(31):4566-4575.
Popovic T, Schmink S, Rosenstein NA, Ajello GW, Reeves MW, Plikaytis B, Hunter SB, Ribot EM, Boxrud D, Tondella ML, Kim C, Noble C, Mothershed E, Besser J, Perkins BA. Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol 2001;39(1):75-85.
Rosenstein NE , Perkins BA, Stephens DS, Popovic T, Hughes JM. Meningococcal disease. N Engl J Med 2001;344:1378-88.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2000. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening00.pdf.
Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA, and the Active Bacterial Core Surveillance Team. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. Clin Infect Dis 2000;30:212-213.
Sacchi CT, Whitney AM, Popovic T, Beall DS, Reeves MW, Plikaytis BD, Rosenstein NE, Perkins BA, Tondella MLC, Mayer LW. Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis 2000;182:1169-1176.
Tondella M, Popovic T, Rosenstein N, Lake D, Carlone G, Perkins B. Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. J Clin Microbiol 2000;38:3323-3328. Back to Top
1995-1999:
Centers for Disease Control and Prevention. 1999. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 1999. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening99.pdf
Diermayer M, Hedberg K, Hoesly F, Fischer M, Perkins B, Reeves M, Fleming D. Epidemic serogroup B meningococcal disease in Oregon : the evolving epidemiology of the ET-5 strain. JAMA. 1999;281(16):1493-1497.
Harrison LH, Dwyer DM, Maples CT, Billmann L. The risk of meningococcal infection in college students. JAMA 1999;281:1906-1910.
Rosenstein NE, Perkins BA, Stephens D, Lefkowitz L, Cartter ML, Danila R, Cieslak P, Shutt KA, Popovic T, Schuchat A, Harrison LH, Reingold AL, and the Active Bacterial Core Surveillance Team. The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis 1999;180:1894-1901.
Yusuf HR, Rochat RW, Baughman WS, Gargiullo PM, Perkins BA, Brantley MD, Stephens DS. Maternal cigarette smoking and invasive meningococcal disease: a cohort study among young children in metropolitan Atlanta, 1989-1996. Am J Public Health 1999;89:712-717.
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 1998. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening98.pdf
Centers for Disease Control and Prevention. Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 1997. Available via the Internet: http://www.cdc.gov/ncidod/dbmd/abcs/survreports/mening97.pdf
Centers for Disease Control and Prevention. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46 (No. RR-5):1-10.
Centers for Disease Control and Prevention. Control and prevention of serogroup C meningococcal disease: evaluation and management of suspected outbreaks: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46 (No. RR-5):13-21.
Fischer M, Hedberg K, Cardosi P, Plikaytis BD, Hoesly FC, Steingart KR, et al. Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J 1997;16:979-983.
Raymond NJ, Reeves M, Ajello G, Baughman W, Gheesling LL, Carlone GM, Wenger JD, Stephens DS. Molecular epidemiology of sporadic (endemic) serogroup C meningococcal disease. J Infect Dis 1997;176:1277-84.
Swartley JS, Marfin AA, Edupuganti S, Liu LJ, Cieslak P, Perkins B, Wenger JD, Stephens DS. Capsule switching of Neisseria meningitidis. Proc Natl Acad Sci 1997; 94:271-276.
Zangwill K, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW, Wenger JD. School-based clusters of meningococcal disease in the United States : descriptive epidemiology and a case-control analysis. JAMA 1997;277:389-395.
Centers for Disease Control and Prevention. Serogroup Y meningococcal disease-- Illinois, Connecticut, and selected areas, United States, 1989-1996. MMWR Morb Mortal Wkly Rep 1996;45:1010-1013.
Centers for Disease Control and Prevention. Serogroup B Meningococcal Disease -- Oregon 1994. MMWR Morb Mortal Wkly Rep 1995;44:121-124.
Jackson LA, Schuchat A, Gorsky RD, Wenger JD. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am J Public Health 1995;85:843-845.
Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States : An emerging threat. JAMA 1995;273:383-389.
Reeves MW, Perkins BA, Diermayer M, Wenger JD. Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerg Infect Dis 1995; 1:53 -54.
Stephens DS, Hajjeh RA, Baughman WS, Harvey CH, Wenger JD, Farley MM. Sporadic meningococcal disease in adults: results of a 5-year population-based study. Ann Intern Med 1995;123:937-940. Back to Top
1988 - 1994:
Jackson LA, Tenover FC, Baker C, Plikaytis BD, Reeves MW, Stocker SA, Weaver RE, Wenger JD, and the Meningococcal Disease Study Group. Prevalence of Neisseria meningitidis relatively resistant to penicillin in the United States, 1991. J Infect Dis 1994;169: 338-341.
Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected counties, United States, 1989-1991. MMWR Morb Mortal Wkly Rep 1993;42:21-30.
Pinner RW, Gellin BG, Bibb WF, Baker CN, Weaver R, Hunter SB, Waterman SH, Mocca LF, Frasch CE, Broome CV, and the Meningococcal Disease Study Group. Meningococcal disease in the United States - 1986. J Infect Dis 1991;164:368-374. Back to Top
|
